VBI Earnings Before Interest Taxes and Depreciation Amortization EBITDA from 2010 to 2024

VBIV Stock  USD 0.60  0.02  3.45%   
Check VBI Vaccines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VBI main balance sheet or income statement drivers, such as Interest Expense of 8.2 M, Selling General Administrative of 51.6 M or Total Revenue of 8.5 M, as well as many exotic indicators such as Price To Sales Ratio of 102, Dividend Yield of 0.0 or Operating Cycle of 232. VBI financial statements analysis is a perfect complement when working with VBI Vaccines Valuation or Volatility modules.
  
This module can also supplement VBI Vaccines' financial leverage analysis and stock options assessment as well as various VBI Vaccines Technical models . Check out the analysis of VBI Vaccines Correlation against competitors.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.

About VBI Vaccines Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include VBI Vaccines income statement, its balance sheet, and the statement of cash flows. VBI Vaccines investors use historical funamental indicators, such as VBI Vaccines's Earnings Before Interest Taxes and Depreciation Amortization EBITDA, to determine how well the company is positioned to perform in the future. Although VBI Vaccines investors may use each financial statement separately, they are all related. The changes in VBI Vaccines's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VBI Vaccines's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VBI Vaccines Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VBI Vaccines. Please read more on our technical analysis and fundamental analysis pages.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out the analysis of VBI Vaccines Correlation against competitors.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.79)
Revenue Per Share
0.689
Quarterly Revenue Growth
19.896
Return On Assets
(0.29)
Return On Equity
(2.20)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.